Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Dogwood Therapeutics, Inc (DWTX) had Income from Continuous Operations of $-4.99M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.99M |
|
-- |
|
-- |
|
$5.08M |
|
$-5.08M |
|
$0.09M |
|
$-4.99M |
|
$-4.99M |
|
$-4.99M |
|
|
Income from Continuous Operations |
$-4.99M |
$-4.99M |
|
$-4.99M |
|
$-5.08M |
|
$-5.08M |
|
33.55M |
|
33.55M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$15.00M |
|
$0.01M |
|
$80.20M |
|
$95.21M |
|
$2.56M |
|
-- |
|
$12.02M |
|
$14.58M |
|
$80.62M |
|
$0.60M |
|
$80.62M |
|
33.40M |
|
| Cash Flow Statement Financials | |
$-4.59M |
|
-- |
|
$11.29M |
|
$6.52M |
|
$13.23M |
|
$6.70M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.19% |
|
-834.39% |
|
-5.24% |
|
-6.19% |
|
$2.41 |
|
$-0.14 |
|
$-0.14 |
|